People are also afraid of tests that involve MRI scans and biopsies. These are the reasons why we are working on developing a test procedure that estimates the risk of prostate cancer precisely ...

"This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and precise results ... as a reliable option for prostate cancer risk assessment across ...

The study identified a set of biomarkers in urine that were able to indicate the presence and severity of prostate cancer with a high degree of precision ... Large-scale clinical trials are ...